Archives of Gynecology and Obstetrics

, Volume 286, Issue 3, pp 667–670 | Cite as

Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis

  • Dietmar Haas
  • Radek Chvatal
  • Björn Reichert
  • Stefan Renner
  • Omar Shebl
  • Helge Binder
  • Peter Wurm
  • Peter Oppelt
General Gynecology



The objectives of this study were to examine the age distribution among women suffering from endometriosis and to establish that endometriosis is not a disease that occurs only in premenopausal women. The null hypothesis was that there are also postmenopausal women with endometriosis.


In a retrospective epidemiological study, a descriptive analysis of data from the Federal Statistical Office in Germany for 2005 and 2006 was carried out. A total of 42,079 women in Germany were admitted for surgical treatment due to histologically confirmed endometriosis during this period. The patients’ age distribution was examined and they were assigned to 5-year age groups and then to premenopausal, perimenopausal, and postmenopausal subgroups.


A total of 20,835 women in 2005 and 21,244 in 2006 were admitted to hospital for the treatment of endometriosis. In the premenopausal group (age 0–45 years), there were 33,814 patients (80.36 %); 23 patients (0.05 %) in this premenopausal group were younger than 15. There were 7,191 patients (17.09 %) in the perimenopausal group (45–55 years), and the postmenopausal group (55–95 years) included 1,074 patients (2.55 %).


The assumption that endometriosis is a disease of the premenopausal period and in women of reproductive age needs to be called into question, as well as the influence of estrogen in fully developed endometriosis. Due to the relatively high prevalence of the condition in patients aged over 40, physicians should consider endometriosis in cases of unclear pelvic pain in this age group.


Endometriosis Age Age pattern Menopausal transition Perimenopause Postmenopause Laparoscopy 



None of the authors has received any financial support for this paper, and it has not previously been presented at any meeting or conference.

Conflict of interest



  1. 1.
    Schweppe KW (2003) Endometriosis—a disease that has no lobby. Zentralbl Gynäkol 125:233 (German)PubMedCrossRefGoogle Scholar
  2. 2.
    Child TJ, Tan SL (2001) Endometriosis: aetiology, pathogenesis and treatment. Drugs 61:1735–1750PubMedCrossRefGoogle Scholar
  3. 3.
    Viganò P, Parazzini F, Somigliana E, Vercellini P (2004) Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 18:177–200PubMedCrossRefGoogle Scholar
  4. 4.
    Sampson JA (1927) Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–469Google Scholar
  5. 5.
    Meyer R (1919) Über den Stand der Frage der Adenomyositis und Adenomyome im Allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa. Zentralbl Gynäkol 36:745–750Google Scholar
  6. 6.
    Noe M, Kunz G, Herbertz M, Mall G, Leyendecker G (1999) The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrial–subendometrial unit. Hum Reprod 14:190–197PubMedCrossRefGoogle Scholar
  7. 7.
    Cicinelli E, De Ziegler D, Nicoletti R et al (2008) Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2,190 consecutive office hysteroscopies. Fertil Steril 89:677–684PubMedCrossRefGoogle Scholar
  8. 8.
    Oppelt P, Renner SP, Strick R et al (2010) Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril 93:1778–1786PubMedCrossRefGoogle Scholar
  9. 9.
    Renner SP, Strick R, Oppelt P et al (2006) Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction 131:153–161PubMedCrossRefGoogle Scholar
  10. 10.
    Treloar SA, Zhao ZZ, Le L et al (2007) Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol Hum Reprod 13:587–594PubMedCrossRefGoogle Scholar
  11. 11.
    Greendale GA, Lee NP, Arriola ER (1999) The menopause. Lancet 353:571–580PubMedCrossRefGoogle Scholar
  12. 12.
    Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT (1993) Impact of climacteric on well-being. A survey based on 5,213 women 39 to 60 years old. Am J Obstet Gynecol 168:772–780PubMedGoogle Scholar
  13. 13.
    Treloar AE (1981) Menstrual cyclicity and the pre-menopause. Maturitas 3:249–264PubMedCrossRefGoogle Scholar
  14. 14.
    Avis NE, McKinlay SM (1995) The Massachusetts Women’s Health Study: an epidemiologic investigation of the menopause. J Am Med Womens Assoc 50:45–49, 63Google Scholar
  15. 15.
    Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799PubMedCrossRefGoogle Scholar
  16. 16.
    Noble LS, Simpson ER, Johns A, Bulun SE (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174–179PubMedCrossRefGoogle Scholar
  17. 17.
    Zeitoun K, Takayama K, Sasano H et al (1998) Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83:4474–4480PubMedCrossRefGoogle Scholar
  18. 18.
    Tehrani FR, Solaymani-Dodaran M, Azizi F (2009) A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 16:797–802PubMedCrossRefGoogle Scholar
  19. 19.
    Shebl O, Ebner T, Sir A et al (2011) Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort. Fertil Steril 95:832–834PubMedCrossRefGoogle Scholar
  20. 20.
    Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12:685–718PubMedCrossRefGoogle Scholar
  21. 21.
    Gindoff PR, Jewelewicz R (1986) Reproductive potential in the older woman. Fertil Steril 46:989–1001PubMedGoogle Scholar
  22. 22.
    Soliman NF, Hillard TC (2006) Hormone replacement therapy in women with past history of endometriosis. Climacteric 9:325–335PubMedCrossRefGoogle Scholar
  23. 23.
    Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A (2009) Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev (1):CD005997Google Scholar
  24. 24.
    Stewart WW, Ireland GW (1977) Vesical endometriosis in a postmenopausal woman: a case report. J Urol 118:480–481PubMedGoogle Scholar
  25. 25.
    Maeda T, Uchida Y, Nakajima F (2009) Vesical endometriosis following the menopause. Int Urogynecol J Pelvic Floor Dysfunct 20:1515–1517PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Dietmar Haas
    • 1
    • 2
  • Radek Chvatal
    • 1
  • Björn Reichert
    • 2
  • Stefan Renner
    • 2
  • Omar Shebl
    • 3
  • Helge Binder
    • 1
    • 2
    • 4
  • Peter Wurm
    • 1
  • Peter Oppelt
    • 1
    • 2
  1. 1.Department of Obstetrics and GynecologyLinz General HospitalLinzAustria
  2. 2.Department of GynecologyErlangen University HospitalErlangenGermany
  3. 3.Landes- Frauen- und Kinderklinik LinzLinzAustria
  4. 4.Kantonsspital UriAltdorfSwitzerland

Personalised recommendations